2024 Q1 Form 10-Q Financial Statement
#000121390024043817 Filed on May 15, 2024
Income Statement
Concept | 2024 Q1 | 2023 Q1 |
---|---|---|
Revenue | $0.00 | $0.00 |
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $30.00K | |
YoY Change | ||
% of Gross Profit | ||
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | ||
YoY Change | ||
% of Gross Profit | ||
Operating Expenses | $700.2K | $386.8K |
YoY Change | 81.02% | 32132.5% |
Operating Profit | -$700.2K | -$386.8K |
YoY Change | 81.02% | 32132.58% |
Interest Expense | $372.7K | $838.6K |
YoY Change | -55.56% | |
% of Operating Profit | ||
Other Income/Expense, Net | $372.7K | $838.6K |
YoY Change | -55.57% | |
Pretax Income | -$327.5K | $451.9K |
YoY Change | -172.48% | -37754.17% |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | -$327.5K | $451.9K |
YoY Change | -172.48% | -37754.33% |
Net Earnings / Revenue | ||
Basic Earnings Per Share | ||
Diluted Earnings Per Share | -$0.07 | $0.10 |
COMMON SHARES | ||
Basic Shares Outstanding | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2024 Q1 | 2023 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $316.0K | $81.95M |
YoY Change | -99.61% | 1655496.77% |
Cash & Equivalents | $316.0K | $54.46K |
Short-Term Investments | ||
Other Short-Term Assets | $74.29K | $80.63K |
YoY Change | -7.86% | -65.33% |
Inventory | ||
Prepaid Expenses | $74.29K | $80.63K |
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $390.3K | $82.03M |
YoY Change | -99.52% | 34438.61% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | ||
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | $29.11M | |
YoY Change | ||
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $29.11M | $0.00 |
YoY Change | ||
TOTAL ASSETS | ||
Total Short-Term Assets | $390.3K | $82.03M |
Total Long-Term Assets | $29.11M | $0.00 |
Total Assets | $29.50M | $82.03M |
YoY Change | -64.04% | 34438.61% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $214.9K | |
YoY Change | ||
Accrued Expenses | $1.121M | $979.2K |
YoY Change | 14.52% | 3633.04% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $900.0K | $530.0K |
YoY Change | 69.81% | 175.74% |
Long-Term Debt Due | $2.298M | |
YoY Change | ||
Total Short-Term Liabilities | $4.534M | $3.872M |
YoY Change | 17.11% | 1672.42% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $2.363M | |
YoY Change | ||
Total Long-Term Liabilities | $2.363M | $0.00 |
YoY Change | ||
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $4.534M | $3.872M |
Total Long-Term Liabilities | $2.363M | $0.00 |
Total Liabilities | $6.896M | $3.872M |
YoY Change | 78.13% | 1672.42% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$6.506M | -$3.737M |
YoY Change | 74.11% | |
Common Stock | $209.00 | |
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$6.506M | -$3.737M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $29.50M | $82.03M |
YoY Change | -64.04% | 34438.61% |
Cashflow Statement
Concept | 2024 Q1 | 2023 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$327.5K | $451.9K |
YoY Change | -172.48% | -37754.33% |
Depreciation, Depletion And Amortization | ||
YoY Change | ||
Cash From Operating Activities | -$582.4K | -$407.3K |
YoY Change | 43.0% | 203526.5% |
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | -$225.0K | |
YoY Change | ||
Cash From Investing Activities | -$225.0K | |
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | $1.066M | $50.00K |
YoY Change | 2032.26% | 870.87% |
NET CHANGE | ||
Cash From Operating Activities | -$582.4K | -$407.3K |
Cash From Investing Activities | -$225.0K | |
Cash From Financing Activities | $1.066M | $50.00K |
Net Change In Cash | $258.7K | -$357.3K |
YoY Change | -172.42% | -7317.23% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$582.4K | -$407.3K |
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
shares | |
CY2023Q1 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
usd | |
CY2024Q1 | dei |
Entity Address Country
EntityAddressCountry
|
GB | |
CY2024Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2024Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2024Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-03-31 | |
CY2024Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | |
CY2024Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2024Q1 | dei |
Entity File Number
EntityFileNumber
|
001-41363 | |
CY2024Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
25 Bedford Square | |
CY2024Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
London | |
CY2024Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
WC1B 3HH | |
CY2024Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2024Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2024Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2024Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2024Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2024Q1 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2024Q1 | dei |
Entity Shell Company
EntityShellCompany
|
true | |
CY2024Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
316030 | usd |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
57290 | usd |
CY2024Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
74287 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
412 | usd |
CY2024Q1 | us-gaap |
Assets Current
AssetsCurrent
|
390317 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
57702 | usd |
CY2024Q1 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
29105841 | usd |
CY2023Q4 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
28508214 | usd |
CY2024Q1 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
29105841 | usd |
CY2023Q4 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
28508214 | usd |
CY2024Q1 | us-gaap |
Assets
Assets
|
29496158 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
28565916 | usd |
CY2024Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1121341 | usd |
CY2023Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
959720 | usd |
CY2024Q1 | clcr |
Notes Payable Current Administrative Service
NotesPayableCurrentAdministrativeService
|
214941 | usd |
CY2023Q4 | clcr |
Notes Payable Current Administrative Service
NotesPayableCurrentAdministrativeService
|
184941 | usd |
CY2024Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4533938 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3226185 | usd |
CY2024Q1 | us-gaap |
Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
|
2362500 | usd |
CY2023Q4 | us-gaap |
Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
|
2362500 | usd |
CY2024Q1 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
2362500 | usd |
CY2023Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
2412500 | usd |
CY2024Q1 | us-gaap |
Liabilities
Liabilities
|
6896438 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
5638685 | usd |
CY2024Q1 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
29105841 | usd |
CY2023Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
28508214 | usd |
CY2024Q1 | clcr |
Total Commitment And Contingencies
TotalCommitmentAndContingencies
|
29105841 | usd |
CY2023Q4 | clcr |
Total Commitment And Contingencies
TotalCommitmentAndContingencies
|
28508214 | usd |
CY2024Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2024Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-6506330 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-5581192 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-6506121 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-5580983 | usd |
CY2024Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
29496158 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
28565916 | usd |
CY2024Q1 | us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
670161 | usd |
CY2023Q1 | us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
356791 | usd |
CY2024Q1 | us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
30000 | usd |
CY2023Q1 | us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
30000 | usd |
CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-700161 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-386791 | usd |
CY2024Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
23 | usd |
CY2024Q1 | us-gaap |
Investment Income Dividend
InvestmentIncomeDividend
|
372627 | usd |
CY2023Q1 | us-gaap |
Investment Income Dividend
InvestmentIncomeDividend
|
858477 | usd |
CY2023Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
-19834 | usd |
CY2024Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
372650 | usd |
CY2023Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
838643 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-327511 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
451852 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-5580983 | usd |
CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
-597627 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-327511 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-6506121 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3329967 | usd |
CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
-858477 | usd |
CY2023Q1 | clcr |
Conversion Of Shares
ConversionOfShares
|
1968749 | shares |
CY2023Q1 | clcr |
Conversion Price Par Value
ConversionPriceParValue
|
0.0001 | |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
451852 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3736592 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-327511 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
451852 | usd |
CY2024Q1 | us-gaap |
Investment Income Dividend
InvestmentIncomeDividend
|
372627 | usd |
CY2023Q1 | us-gaap |
Investment Income Dividend
InvestmentIncomeDividend
|
858477 | usd |
CY2023Q1 | us-gaap |
Costs And Expenses Related Party
CostsAndExpensesRelatedParty
|
19834 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
161621 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-71079 | usd |
CY2024Q1 | clcr |
Increase Decrease In Administrative Service Fee Payable Related Party
IncreaseDecreaseInAdministrativeServiceFeePayableRelatedParty
|
30000 | usd |
CY2023Q1 | clcr |
Increase Decrease In Administrative Service Fee Payable Related Party
IncreaseDecreaseInAdministrativeServiceFeePayableRelatedParty
|
24701 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
73875 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-25916 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-582392 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-407253 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
|
225000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-225000 | usd |
CY2024Q1 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
766132 | usd |
CY2023Q1 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
50000 | usd |
CY2024Q1 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
300000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1066132 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
50000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
258740 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-357253 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
57290 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
411711 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
316030 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
54458 | usd |
CY2024Q1 | clcr |
Remeasurement Adjustment On Public Shares Subject To Possible Redemption
RemeasurementAdjustmentOnPublicSharesSubjectToPossibleRedemption
|
597627 | usd |
CY2024Q1 | us-gaap |
Payments For Underwriting Expense
PaymentsForUnderwritingExpense
|
1181250 | usd |
CY2024Q1 | us-gaap |
Payments For Commissions
PaymentsForCommissions
|
2362500 | usd |
CY2024Q1 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
604011 | usd |
CY2024Q1 | us-gaap |
Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
|
79931250 | usd |
CY2024Q1 | us-gaap |
Cash Acquired From Acquisition
CashAcquiredFromAcquisition
|
316030 | usd |
CY2024Q1 | clcr |
Assets Held In Trust Account
AssetsHeldInTrustAccount
|
0.80 | pure |
CY2024Q1 | clcr |
Interest Earned On The Funds Held In The Trust Account
InterestEarnedOnTheFundsHeldInTheTrustAccount
|
11.29 | |
CY2024Q1 | us-gaap |
Deposits
Deposits
|
787500 | usd |
CY2024Q1 | clcr |
Deposits Per Share
DepositsPerShare
|
0.1 | |
CY2023Q2 | clcr |
Sponsor Loan
SponsorLoan
|
75000 | usd |
CY2024Q1 | us-gaap |
Cash
Cash
|
316030 | usd |
CY2024Q1 | clcr |
Working Capital Deficit
WorkingCapitalDeficit
|
4143621 | usd |
CY2024Q1 | us-gaap |
Fiscal Period
FiscalPeriod
|
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Prior period reclassifications</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">To conform with the current period presentation, management has reclassified a portion of the amount previously presented within “Formation and operating costs” on the statement of operations for the quarter ended March 31, 2023, and “Accrued liabilities, excluding unrealized foreign exchange loss” on the statement of cash flows for the quarter ended March 31, 2023 to report “Administrative service fees - related party” and “Administrative service fee payable - related party”, respectively.</p> | |
CY2024Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
316030 | usd |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
57290 | usd |
CY2024Q1 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
29105841 | usd |
CY2023Q4 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
28508214 | usd |
CY2024Q1 | us-gaap |
Investment Income Dividend
InvestmentIncomeDividend
|
372627 | usd |
CY2023Q1 | us-gaap |
Investment Income Dividend
InvestmentIncomeDividend
|
858477 | usd |
CY2024Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Accordingly, the actual results could differ significantly from those estimates.</p> | |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-327511 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
451852 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
|
225000 | usd |
CY2024Q1 | us-gaap |
Investment Income Dividend
InvestmentIncomeDividend
|
372627 | usd |
CY2023Q1 | us-gaap |
Investment Income Dividend
InvestmentIncomeDividend
|
858477 | usd |
CY2024Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
925138 | usd |
CY2023Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
406625 | usd |
CY2024Q1 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
78750000 | usd |
CY2023Q4 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
78750000 | usd |
CY2024Q1 | clcr |
Proceeds Allocated To Public Warrants And Public Rights
ProceedsAllocatedToPublicWarrantsAndPublicRights
|
6898500 | usd |
CY2023Q4 | clcr |
Proceeds Allocated To Public Warrants And Public Rights
ProceedsAllocatedToPublicWarrantsAndPublicRights
|
6898500 | usd |
CY2024Q1 | clcr |
Reclassification Of Offering Costs Related To Public Shares
ReclassificationOfOfferingCostsRelatedToPublicShares
|
4647702 | usd |
CY2023Q4 | clcr |
Reclassification Of Offering Costs Related To Public Shares
ReclassificationOfOfferingCostsRelatedToPublicShares
|
4647702 | usd |
CY2024Q1 | us-gaap |
Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
|
55265334 | usd |
CY2023Q4 | us-gaap |
Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
|
55265334 | usd |
CY2024Q1 | us-gaap |
Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
|
16342377 | usd |
CY2023Q4 | us-gaap |
Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
|
15969750 | usd |
CY2024Q1 | clcr |
Monthly Extension Fees
MonthlyExtensionFees
|
825000 | usd |
CY2023Q4 | clcr |
Monthly Extension Fees
MonthlyExtensionFees
|
600000 | usd |
CY2024Q1 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
29105841 | usd |
CY2023Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
28508214 | usd |
CY2022Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
11.5 | |
CY2022Q2 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
375000 | shares |
CY2022Q2 | clcr |
Founder Shares Were No Longer Subject To Forfeiture
FounderSharesWereNoLongerSubjectToForfeiture
|
93750 | shares |
CY2022Q2 | clcr |
Number Of Shares Subject To Forfeiture
NumberOfSharesSubjectToForfeiture
|
187500 | shares |
CY2024Q1 | clcr |
Due To Affiliate
DueToAffiliate
|
170603 | usd |
CY2023Q4 | clcr |
Due To Affiliate
DueToAffiliate
|
170603 | usd |
CY2022Q4 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
300000 | usd |
CY2023Q1 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
50000 | usd |
CY2023Q2 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
150000 | usd |
CY2023Q2 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
125000 | usd |
CY2023Q2 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
125000 | usd |
CY2023Q3 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
100000 | usd |
CY2024Q1 | us-gaap |
Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
|
653619 | usd |
CY2023Q4 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
335000 | usd |
CY2023Q4 | us-gaap |
Investment Interest Rate Paid In Cash
InvestmentInterestRatePaidInCash
|
0.05 | pure |
CY2024Q1 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
788434 | usd |
CY2023 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
22302 | usd |
CY2023Q4 | us-gaap |
Other Loans Payable
OtherLoansPayable
|
357302 | usd |
CY2023Q4 | clcr |
Interest Rate Percentage
InterestRatePercentage
|
0.05 | pure |
CY2023Q2 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
900000 | usd |
CY2023Q2 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
75000 | usd |
CY2023Q2 | clcr |
Interest Rate Percentage
InterestRatePercentage
|
0.05 | pure |
CY2023Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
1 | |
CY2024Q1 | us-gaap |
Product Liability Contingency Loss Exposure Not Accrued Best Estimate
ProductLiabilityContingencyLossExposureNotAccruedBestEstimate
|
900000 | usd |
CY2023 | us-gaap |
Product Liability Contingency Loss Exposure Not Accrued Best Estimate
ProductLiabilityContingencyLossExposureNotAccruedBestEstimate
|
600000 | usd |
CY2024Q1 | clcr |
Notes Payable Current Administrative Service
NotesPayableCurrentAdministrativeService
|
214941 | usd |
CY2023Q4 | clcr |
Notes Payable Current Administrative Service
NotesPayableCurrentAdministrativeService
|
184941 | usd |
CY2022Q3 | us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
500000 | usd |
CY2022Q3 | clcr |
Purchase Price
PurchasePrice
|
400000000 | usd |
CY2022Q3 | clcr |
Total Remuneration Transaction Price
TotalRemunerationTransactionPrice
|
400000001 | usd |
CY2022Q3 | clcr |
Transactions Purchase Price
TransactionsPurchasePrice
|
1000000 | usd |
CY2022Q4 | us-gaap |
Payment For Administrative Fees
PaymentForAdministrativeFees
|
250000 | usd |
CY2022Q4 | us-gaap |
Additional Collateral Aggregate Fair Value
AdditionalCollateralAggregateFairValue
|
400000000 | usd |
CY2024Q1 | clcr |
Cash Fee Payable Percentage
CashFeePayablePercentage
|
0.02 | pure |
CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
|
375000 | shares |
CY2024Q1 | us-gaap |
Other Underwriting Expense
OtherUnderwritingExpense
|
0.45 | usd |
CY2024Q1 | us-gaap |
Litigation Settlement Expense
LitigationSettlementExpense
|
125000 | usd |
CY2024Q1 | clcr |
Upfront Retainer Amount
UpfrontRetainerAmount
|
37500 | usd |
CY2024Q1 | clcr |
Billed Balance Percentage
BilledBalancePercentage
|
0.50 | pure |
CY2024Q1 | clcr |
Outstanding Balance Percentage
OutstandingBalancePercentage
|
0.50 | pure |
CY2024Q1 | clcr |
Initial Business Combination Paid Percentage
InitialBusinessCombinationPaidPercentage
|
0.20 | pure |
CY2024Q1 | clcr |
Outstanding Billed Amount For Services Provided
OutstandingBilledAmountForServicesProvided
|
895679 | usd |
CY2023 | clcr |
Outstanding Billed Amount For Services Provided
OutstandingBilledAmountForServicesProvided
|
892784 | usd |
CY2024Q1 | clcr |
Outstanding Balance Amount
OutstandingBalanceAmount
|
447840 | usd |
CY2023 | clcr |
Outstanding Balance Amount
OutstandingBalanceAmount
|
446392 | usd |
CY2023 | clcr |
Outstanding Balance Percentage
OutstandingBalancePercentage
|
0.50 | pure |
CY2023Q1 | clcr |
Gross Proceeds Received Percentage
GrossProceedsReceivedPercentage
|
0.01 | pure |
CY2022Q3 | us-gaap |
Principal Transactions Revenue
PrincipalTransactionsRevenue
|
50000000 | usd |
CY2022Q3 | us-gaap |
Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
|
150000 | usd |
CY2022Q3 | us-gaap |
Payments For Fees
PaymentsForFees
|
40000000 | usd |
CY2022Q3 | clcr |
Transaction Success Fee
TransactionSuccessFee
|
500000 | usd |
CY2022Q3 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
15000 | usd |
CY2022Q3 | us-gaap |
Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
|
20000 | usd |
CY2022Q3 | clcr |
Aggregate Transaction Value
AggregateTransactionValue
|
400000000 | usd |
CY2022Q3 | clcr |
Retainer Fees
RetainerFees
|
40000 | usd |
CY2024Q1 | clcr |
Transactions Payable
TransactionsPayable
|
1600000 | usd |
CY2024Q1 | clcr |
Transactions Behalf Payable
TransactionsBehalfPayable
|
1600000 | usd |
CY2024Q1 | clcr |
Aggregate Transaction Value
AggregateTransactionValue
|
300000000 | usd |
CY2024Q1 | clcr |
Transaction Purchase Price
TransactionPurchasePrice
|
0.0085 | pure |
CY2024Q1 | us-gaap |
Fair Value Option Aggregate Differences Long Term Debt Instruments
FairValueOptionAggregateDifferencesLongTermDebtInstruments
|
300000000 | usd |
CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
|
0.004 | pure |
CY2024Q1 | clcr |
Transaction Success Fee
TransactionSuccessFee
|
1000000 | eur |
CY2024Q1 | us-gaap |
Subsequent Event Effect Of Change In Tax Status
SubsequentEventEffectOfChangeInTaxStatus
|
120000 | usd |
CY2024Q1 | us-gaap |
Other Payments To Acquire Businesses
OtherPaymentsToAcquireBusinesses
|
650000000 | usd |
CY2024Q1 | clcr |
Shares Based On The Achievement Amount
SharesBasedOnTheAchievementAmount
|
150000000 | usd |
CY2024Q1 | us-gaap |
Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
|
52000000 | usd |
CY2024Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2024Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q1 | clcr |
Redemption Price Per Warrant
RedemptionPricePerWarrant
|
0.01 | |
CY2024Q1 | clcr |
Number Of Days For Written Notice Of Redemption
NumberOfDaysForWrittenNoticeOfRedemption
|
P30D | |
CY2024Q1 | clcr |
Minimum Threshold Price Of Common Stock Specified To Send Notice Of Redemption To The Warrant Holders
MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders
|
18 | |
CY2024Q1 | clcr |
Common Stock Threshold Trading Days
CommonStockThresholdTradingDays
|
20 | pure |
CY2024Q1 | clcr |
Common Stock Threshold Consecutive Trading Days
CommonStockThresholdConsecutiveTradingDays
|
30 | pure |
CY2024Q1 | clcr |
Price Threshold Of Newly Issued Stock To Cause Adjustment Of Exercise Warrant Price
PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice
|
9.2 | |
CY2024Q1 | clcr |
Price Threshold Of Newly Issued Stock To Cause Adjustment Of Exercise Warrant Price Percentage Of Equity Proceeds From Issuance
PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPricePercentageOfEquityProceedsFromIssuance
|
0.60 | pure |
CY2024Q1 | clcr |
Percentage Of Warrant Exercise Price Adjusted To Price Received In New Issuance
PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance
|
1.15 | pure |
CY2024Q1 | clcr |
Class Of Warrant Or Right Target Share Price Of Warrants Or Rights For Redemption
ClassOfWarrantOrRightTargetSharePriceOfWarrantsOrRightsForRedemption
|
18 | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2024Q1 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
CY2024Q1 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2023Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
usd | |
CY2024Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
usd | |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
usd | |
CY2024Q1 | us-gaap |
Costs And Expenses Related Party
CostsAndExpensesRelatedParty
|
usd | |
CY2023Q1 | us-gaap |
Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
|
usd | |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | |
CY2023Q1 | clcr |
Remeasurement Adjustment On Public Shares Subject To Possible Redemption
RemeasurementAdjustmentOnPublicSharesSubjectToPossibleRedemption
|
usd | |
CY2023Q1 | us-gaap |
Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
|
usd | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
shares | |
CY2024Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2024Q1 | dei |
City Area Code
CityAreaCode
|
+44 | |
CY2024Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2024Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2024Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001903392 |